D-Kynurenine
CAS: 13441-51-5
Ref. 3D-FK145481
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen | ||
250mg | Ausgelaufen |
Produktinformation
- (2R)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid
- (αR)-α,2-Diamino-γ-oxobenzenebutanoic acid
- <span class="text-smallcaps">D</span>-Kynurenine
- Alanine, 3-anthraniloyl-, <span class="text-smallcaps">D</span>-
- Benzenebutanoic acid, α,2-diamino-γ-oxo-, (R)-
- Benzenebutanoic acid, α,2-diamino-γ-oxo-, (αR)-
- Alanine, 3-anthraniloyl-, D-
D-Kynurenine is a product of tryptophan metabolism that has been shown to be involved in the development of cancer. It has been shown to inhibit acetylcholine release and cause cell death in rats. D-Kynurenine also acts as a chemoattractant for white blood cells, and it is thought to be involved in the regulation of camp levels. In humans, d-kynurenine is produced by the enzyme quinolinate phosphoribosyltransferase from 3-hydroxyanthranilic acid, which is converted from L-tryptophan by the enzyme indoleamine 2,3-dioxygenase. The optimum pH for this reaction is 7.4 and its maximum activity occurs at 37°C. D-Kynurenine may have therapeutic potential for the treatment of acetylcholine deficiency diseases such as Alzheimer's disease or Parkinson's disease due to its ability to increase acetylch